LGVN

Longeveron LLC (LGVN) is a cutting-edge clinical-stage biotechnology firm based in Miami, Florida, focused on pioneering cell therapies for critical and age-related medical conditions. The company is at the forefront of utilizing mesenchymal stem cells to tackle prevalent health challenges, including cognitive decline and cardiac frailty. With a commitment to scientific rigor and regulatory compliance, Longeveron aims to redefine treatment landscapes and enhance patient care through its innovative therapeutic solutions. As it progresses with its proprietary technologies, Longeveron is strategically positioned to revolutionize the field of regenerative medicine and deliver transformative health outcomes.